Foley is pleased to be a Gold sponsor of the Sino-American Biomedical and Pharmaceutical Association (SABPA) 5th Annual Pacific Forum. The conference brings together entrepreneurs, scientists, investors, executives, and policy makers to promote life sciences and biotechnology alliances across the Pacific Rim, including the U.S. West coast, greater China region, and Singapore.
Foley Partner Stephen Bent will participate on a panel discussion on November 7th at 2:30 p.m. on “What is Your China Play – Doing Business in a Shifting Regulatory, Investment, and Economic Environment.”
For more information about the SABPA 5th Annual Pacific Forum, please visit the SABPA Web site.
People
Related Insights
31 December 2024
Foley Viewpoints
SEC Enforcement Action Against Church & Dwight Director: Lessons for Outside Directors
The SEC’s settlement with James R. Craigie, former CEO, chairman, and director of Church & Dwight Co. Inc., for violating proxy disclosure rules by standing for election as an independent director without disclosing his close personal friendship with a senior Church & Dwight executive has caused consternation in the legal community regarding when a friendship jeopardizes director independence under stock exchange rules.
31 December 2024
Manufacturing Industry Advisor
The State of the Law of Requirements Contracts
Amid increasing pressure on supply chains across the globe, multiple recent court opinions have disrupted the law of requirements contracts.
30 December 2024
Foley Viewpoints
Controlling Entities to Dealer Contracts Subject to Puerto Rico’s Law 75 May Be Liable for Tortious Interference
Plaintiffs asserting claims for tortious interference of contracts covered by Puerto Rico’s Dealer’s Contracts Act, commonly known as Law 75, may automatically satisfy one element of such a claim. Law 75 regulates relationships between distributors and manufacturers.